Alzheimer’s Disease/Dementia News

A new study demonstrated that obstructive sleep apnea has an acute effect on biomarkers for Alzheimer’s disease and the ability to measure such biomarkers from blood.

Angiotensin receptor blockers may reduce progression from mild cognitive impairment to dementia in patients undergoing antihypertensive treatment, researchers wrote in Hypertension.

Individuals aged 65 years and older with a history of hypothyroidism were associated with an 81% increased risk for dementia, researchers reported in Neurology.

Drugs that target the noradrenergic system may improve cognition and apathy in patients with dementia or mild cognitive impairment caused by Alzheimer’s disease but have little effect on attention or episodic memory, researchers reported.

PTSD was associated with accelerated decline in cognitive function in middle-aged women, researchers reported in JAMA Network Open.

A thin optical fiber shows promise for use in minimally invasive deep tissue studies in brains affected by Alzheimer’s disease, researchers reported in APL Photonics.

Mdoloris, a company specializing in medical pain monitoring technologies, announced its latest device, a bracelet that can record and track the pain and well-being of those who are unable to verbalize or indicate what they are feeling.

Men who experience behavioral changes, such as apathy or hallucinations, are at a faster risk for cognitive decline compared with women, findings published in the Journal of Alzheimer’s Disease showed.

Acadia Pharmaceuticals Inc. announced the outcome of the FDA advisory committee meeting on the use of pimavanserin for treating hallucinations and delusions associated with Alzheimer’s disease psychosis.

Those diagnosed with dementia faced a greater risk for COVID-19 breakthrough infections and hospitalizations than those without, according to a study published in Alzheimer’s & Dementia.